Cost Plus Drugs: EXPLAINED | Mark Cuban Full Interview

Cost Plus Drugs: EXPLAINED | Mark Cuban Full Interview

The Twenty Minute VCFeb 8, 202230m

Harry Stebbings (host), Mark Cuban (guest)

Cost Plus Drugs’ business model and pricing structureRegulatory and structural problems in the US healthcare and pharma ecosystemBootstrapping, capital allocation, and scaling a mission-driven companyHiring philosophy, management style, and organizational cultureMarketing without heavy ad spend and leveraging customer trust/word-of-mouthMisaligned incentives in insurance and hospital systemsPersonal beliefs: parenting, climate change, reading, and life priorities

In this episode of The Twenty Minute VC, featuring Harry Stebbings and Mark Cuban, Cost Plus Drugs: EXPLAINED | Mark Cuban Full Interview explores mark Cuban’s Cost Plus Drugs Attacks Soaring Prescription Prices Head-On Mark Cuban discusses Cost Plus Drugs, his self-funded company aiming to radically lower the price of generic medications through transparent, fixed-margin pricing. The business avoids insurance and pharmacy benefit managers (PBMs), instead selling directly to consumers at cost plus a 15% markup, a $3 handling fee, and $5 shipping. Cuban details the regulatory and supply-chain complexities of building a new kind of pharmacy and why having no outside investors lets him prioritize impact over profit. He also shares broader views on healthcare system misalignments, his philosophy on hiring, management, and goal setting, and personal perspectives on parenting, climate risk, and life priorities.

Mark Cuban’s Cost Plus Drugs Attacks Soaring Prescription Prices Head-On

Mark Cuban discusses Cost Plus Drugs, his self-funded company aiming to radically lower the price of generic medications through transparent, fixed-margin pricing. The business avoids insurance and pharmacy benefit managers (PBMs), instead selling directly to consumers at cost plus a 15% markup, a $3 handling fee, and $5 shipping. Cuban details the regulatory and supply-chain complexities of building a new kind of pharmacy and why having no outside investors lets him prioritize impact over profit. He also shares broader views on healthcare system misalignments, his philosophy on hiring, management, and goal setting, and personal perspectives on parenting, climate risk, and life priorities.

Key Takeaways

Radical price transparency can undercut traditional drug pricing structures.

By openly publishing a simple formula—drug cost plus 15%, $3 handling, $5 shipping—and bypassing insurance and PBMs, Cost Plus often beats both cash prices and insurance copays on generics.

Get the full analysis with uListen AI

Self-funding enables mission-first decisions over profit maximization.

Because Cuban has no outside investors, he can tolerate revenue volatility and resist pressure to add high-margin features or marketing, keeping focus on being the lowest-cost generic provider.

Get the full analysis with uListen AI

Success hinges on hiring exceptional operators and then delegating deeply.

Cuban emphasizes working with ‘rock star’ partners like Dr. ...

Get the full analysis with uListen AI

Hire slow, fire fast—and distinguish stress removers from stress creators.

He advocates careful hiring, rapid exits for poor fits, and categorizing people by whether they reduce or manufacture stress; the former should be protected, the latter removed quickly.

Get the full analysis with uListen AI

Define goals around core customer value, not just revenue targets.

For Cost Plus, key metrics are repeat customers, number of drugs offered, and continuous price reductions; revenue and profit are secondary to building trust as the lowest-cost provider.

Get the full analysis with uListen AI

Organic, trust-based marketing can replace big ad budgets when value is clear.

Cuban wants new drug additions and ongoing price cuts themselves to be the marketing, counting on patient communities and word-of-mouth rather than large paid campaigns.

Get the full analysis with uListen AI

Healthcare’s misaligned incentives drive up prices and administrative waste.

He critiques how insurance medical loss ratios and hospital contracting reward higher gross spending, contributing to roughly 21% of US healthcare costs going to administration rather than care.

Get the full analysis with uListen AI

Notable Quotes

Our goal is to be the lowest cost provider of generic drugs, period, end of story.

Mark Cuban

I’m financing it all myself… when you bring on investors, you’re gonna run it differently.

Mark Cuban

I really divide people into stress creators and stress removers. The stress removers, you do everything you can to keep them.

Mark Cuban

We’re not trying to optimize revenues, we’re not trying to optimize profits. We’re trying to optimize how many customers we have.

Mark Cuban

Time is the most valuable asset you don’t own.

Mark Cuban

Questions Answered in This Episode

How scalable is the Cost Plus model once you move beyond generics and into branded or specialty drugs?

Mark Cuban discusses Cost Plus Drugs, his self-funded company aiming to radically lower the price of generic medications through transparent, fixed-margin pricing. ...

Get the full analysis with uListen AI

What specific regulatory or industry pushback does Cuban anticipate if Cost Plus reaches tens of millions of customers?

Get the full analysis with uListen AI

Could Cost Plus ever integrate with insurance in a way that preserves its transparency and low prices?

Get the full analysis with uListen AI

How might technologies like DAOs and decentralized validation realistically change insurance and claims processing in the next decade?

Get the full analysis with uListen AI

If 21% of US healthcare spending is administrative, what concrete structural reforms does Cuban believe are most politically feasible to reduce that overhead?

Get the full analysis with uListen AI

Transcript Preview

Harry Stebbings

(beeping) Three, two, one, zero. You have now arrived at your destination. Mark, this is such a joy to do. First, thank you so much for joining me today. I've been so looking forward to this one.

Mark Cuban

Thanks for having me. I'm looking forward to it too.

Harry Stebbings

Well, I, now I've done many, many shows as you know, uh, and we always start with the story and the context, but this is just too exciting and, you know, we've, we've, we've done the context before, so I want to dive right in. You recently announced Cost Plus Drugs, and so for those that maybe don't know-

Mark Cuban

(laughs)

Harry Stebbings

... what is Cost Plus and why are you doing it, Mark?

Mark Cuban

Well, the first question, what is Cost Plus? If you go to costplusdrugs.com, the goal for us is to take generic drugs and be very transparent in what our costs and operation costs are and sell everything at a 15% markup. And from there, we add a $3 handling fee and a $5 shipping fee, um, and that's your price. And just the way the industry is set up, that price, not always but 99% of the time, ends up being lower than what you're probably already paying, and most likely it's lower than your insurance copay. And to answer your second question, why, because I could, you know? And it was the right thing to do.

Harry Stebbings

Can I ask a bit of a weird one?

Mark Cuban

Uh-huh.

Harry Stebbings

For me when I listened, I was like, "Why has no one done this before?" If they're generic drugs, what, why, why has no one done it before?

Mark Cuban

You know what? They've done it in a variety of ways, um, or tried, but the challenge is I get to f-... You know, I didn't bring on any investors. Um, I'm financing it all myself, and when you bring on investors or you run it to maximize or optimize your profits, you're gonna run it differently, and that's just not what we're trying to do. We're, you know, we have a very specific purpose, and that's to be the lowest cost provider of generic drugs, period, end of story, which means we're not gonna have all the bells and whistles that somebody like GoodRx is going to have. You're not gonna have, you know, you know, famous doctors writing blog posts to tell you about your IBS. And tho- those things are all great. I'm not, you know, diminishing them at all, but there are just certain people that don't need the bells and whistles. Their back's against the wall, and they need their medication as inexpensively as they possibly can get it, and that's what we're trying to solve.

Harry Stebbings

Uh, listen, I, I, I totally get that. Can I ask, just to place some structure around it, in terms of the current ecosystem and how it's structured and why, like why are these drugs so expensive? What's the structure that makes them that way?

Install uListen to search the full transcript and get AI-powered insights

Get Full Transcript

Get more from every podcast

AI summaries, searchable transcripts, and fact-checking. Free forever.

Add to Chrome